Pyoderma gangrenosum and systemic treatment
نویسندگان
چکیده
منابع مشابه
Adalimumab treatment for pyoderma gangrenosum.
A 47-year-old woman was referred to Washington University dermatology clinic for a nonhealing ulcer on her right shin of 8 months’ duration. She reported having had a similar ulcer on her left shin 6 years ago. The patient’s medical history was significant for non–insulin-dependent diabetes mellitus, hypertension, and osteoarthritis. On examination, she was found to have a 2 3-cm punched-out ul...
متن کاملPyoderma gangrenosum.
Pyoderma gangrenosum (PG) is an idiopathic, ulcerative, noninfective chronic inflammatory skin disorder of unknown etiology. It is associated with systemic medical illness in 50% of cases like inflammatory bowel disease, systemic arthritis, haematological diseases and malignancies. Characteristic lesions begin as pustule or vesiculopustule and progresses to an ulcer or deep erosion with violace...
متن کاملPyoderma gangrenosum treatment: a steroid-free option.
65 Year-old female with Rheumatoid Arthritis for 20 years developed open wounds on bilateral lower extremities. She was treated by her primary care physician for over a year with multiple dressing including wet to dry and Silvadine. The patient presented to the wound care center, a biopsy was done and a diagnosis of Pyoderma Gangrenosum was made. The patient began using Hydrofera BlueTM dressin...
متن کاملPyoderma gangrenosum in a patient with antiphospholipid antibody negative systemic lupus erythematosus: A case report
In any description of leg ulcers in systemic lupus erythematosus (SLE), pyoderma gangrenosum (PG) earns a mention at least for its being quite rare in such patients. The causative role of aPL (antiphospholipid antibody) in dermatological manifestations of SLE is undermined by the occurrence of PG in aPL negative SLE patients. To the best of our knowledge, there are only two reports of PG in aPL...
متن کاملIbrutinib-induced pyoderma gangrenosum.
710 started an oral ibrutinib therapy (3 × 140 mg/d), due to B-CLL. An ulcer biopsy revealed lymphocyte and neutrophil infiltration. No histopathologic signs of carcinoma or vasculitis were observed. After consultation with a hematologist, a tentative diagnosis of ibrutinib-induced pyoderma gangrenosum (PG) was established. In addition to ibrutinib discontinuation, daily prednisone dose was inc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Dermatology
سال: 2018
ISSN: 0007-0963
DOI: 10.1111/bjd.16952